• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    GERD and NERD Treatment Market Analysis

    ID: MRFR/Pharma/4106-CR
    90 Pages
    Rahul Gotadki
    February 2018

    Americas Gerd and Nerd Treatment Market Research Report Information, By Drug Class (Antacids (Acid Neutralizers), Proton Pump Inhibitors, H2 Receptor Blocker), Dosage Form (Solid And Liquid), End User (Hospitals and Clinics, Research Centers, And Others) -Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GERD and NERD Treatment Market Infographic
    Purchase Options

    Market Analysis

    In-depth Analysis of GERD and NERD Treatment Market Industry Landscape

    Gastroesophageal reflux disease (GERD) and non-erosive reflux sickness (NERD) are conventional gastrointestinal disorders characterized by way of the reflux of belly acid into the esophagus, leading to symptoms that include heartburn, regurgitation, and chest pain. The high prevalence of these situations, affecting thousands and thousands of individuals internationally, drives the demand for effective treatment options and impacts market dynamics considerably. Advances in diagnostic strategies, including top endoscopy, ambulatory pH monitoring, and esophageal manometry, have progressed the analysis and characterization of GERD and NERD Treatment. Accurate diagnosis is crucial for steering remedy selections and monitoring disease development, impacting market dynamics with the aid of influencing treatment choice and affected person results. The treatment panorama for GERD and NERD Treatment consists of lifestyle changes, pharmacological healing procedures, and surgical interventions aimed at lowering acid reflux disease, assuaging signs, and preventing headaches. Proton pump inhibitors (PPIs) are typically prescribed as first-line pharmacological remedies for GERD and NERD Treatment. However, a few patients may require alternative remedies, which include histamine receptor antagonists (H2RAs), antacids, or surgical interventions like fundoplication. The market for GERD and NERD treatment is characterized by extreme competition among pharmaceutical organizations, medical tool manufacturers, and healthcare carriers. Market dynamics are prompted by means of elements such as product innovation, pricing strategies, distribution channels, and strategic collaborations. Companies attempt to distinguish their products through advanced capabilities, improved efficacy, and patient-pleasant formulations to benefit a competitive side inside the market. Patient preferences, such as treatment adherence and first-class of existence effects, affect the adoption of particular treatment modalities in the GERD and NERD Treatment market. Improvements in symptom management, symptom remedy, and long-term quality of lifestyles are key considerations for patients while deciding on remedy options. Patient-targeted care and shared selection-making contribute to market dynamics by shaping remedy picks and healthcare delivery trends. Regional versions in healthcare infrastructure, cultural attitudes toward GERD and NERD Treatment, and the right of entry to specialized care impact market dynamics. Ongoing technological innovations in GERD and NERD Treatment remedies, which include minimally invasive endoscopic tactics, wi-fi pH monitoring devices, and impedance checking out, make contributions to the evolving market dynamics. These improvements improve diagnostic accuracy, treatment efficacy, and patient effects, addressing unmet needs and riding the demand for innovative answers in reflux management. Investment in studies and development efforts for GERD and NERD Treatment remedies is driven by elements that include market demand, technological advancements, and regulatory incentives. Funding from authorities, businesses, personal buyers, and philanthropic corporations supports innovation inside the GERD and NERD Treatment market and impacts market dynamics. The GERD and NERD Treatment remedy market is anticipated to witness a persistent increase and innovation pushed via improvements in technology, growing demand for patient-centered care, and a growing emphasis on personalized remedies in healthcare. Collaboration between stakeholders, funding in studies and development efforts, and coverage initiatives geared toward enhancing admission to specialized care will play an essential position in shaping the destiny dynamics of the GERD and NERD Treatment market.

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

    Americas GERD & NERD treatment market is projected to grow at a 7.63% CAGR By 2032

    Which region is expected to dominate the GERD & NERD treatment market?

    The Americas is expected to dominate the GERD & NERD treatment market.

    What are the key factors driving the Americas GERD & NERD treatment market?

    Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD & NERD treatment market.

    Which drug class segment will dominate the Americas GERD & NERD treatment market?

    Proton pump inhibitors will dominate the GERD & NERD treatment market.

    What are the end users of the Americas GERD & NERD treatment market?

    End users of the GERD & NERD treatment market include research centers, hospitals and clinics, and others.

    Market Summary

    The Global Americas GERD and NERD Treatment Market is projected to grow significantly from 2.16 USD Billion in 2024 to 5.22 USD Billion by 2035.

    Key Market Trends & Highlights

    Americas GERD & NERD Treatment Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.36% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 5.22 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 2.16 USD Billion, reflecting the current demand for GERD and NERD treatments.
    • Growing adoption of innovative treatment options due to increasing prevalence of GERD and NERD is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.16 (USD Billion)
    2035 Market Size 5.22 (USD Billion)
    CAGR (2025-2035) 8.36%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    AstraZeneca Plc (U.K), Boston Scientific Corporation (U.S.), Cempra Inc. (U.S.), Eisai Co., Ltd. (Japan), EndoGastric Solutions Inc. (U.S.), EndoStim Inc. (U.S.), GlaxoSmithKline Plc (U.K), Ironwood Pharmaceuticals, Inc. (U.S.), Jeil pharmaceutical Co.Ltd. (South Korea), Johnson & Johnson (U.S.), Mederi Therapeutics Inc. (U.S.), Medigus Ltd. (Israel), Medtronic Inc. (U.S.), Merck & CO., Inc. (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Takeda Pharmaceutical Company Limited (Japan), Teva Pharmaceuticals Industries Limited (Israel), Torax Medical (U.S.), Valeant Pharmaceuticals International, Inc. (Canada), Carbon Medical technologies (U.S.), Allegiant health (U.S.), Tya pharmaceuticals (U.S.), Sanofi (France)

    Market Trends

    The increasing prevalence of gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD) in the Americas suggests a growing demand for effective treatment options, as healthcare providers seek to address the rising burden of these conditions on public health.

    Centers for Disease Control and Prevention (CDC)

    GERD and NERD Treatment Market Market Drivers

    Aging Population

    The aging population in the Americas serves as a significant driver for the Global Americas GERD and NERD Treatment Market Industry. As individuals age, the prevalence of GERD and NERD tends to increase due to physiological changes and comorbidities associated with older age. This demographic shift necessitates a greater focus on treatment options tailored to the needs of older adults. With the population aged 65 and older projected to reach 80 million by 2040, the demand for effective GERD and NERD treatments is expected to rise correspondingly, thereby propelling market growth.

    Market Growth Projections

    The Global Americas GERD and NERD Treatment Market Industry is projected to experience substantial growth over the next decade. With an estimated market value of 2.16 USD Billion in 2024, it is expected to expand to 5.22 USD Billion by 2035, reflecting a CAGR of 8.36 percent from 2025 to 2035. This growth trajectory indicates a robust response to the increasing prevalence of GERD and NERD, advancements in treatment options, and heightened awareness among patients and healthcare providers. The market dynamics suggest a promising future for stakeholders involved in the development and distribution of GERD and NERD treatments.

    Increased Awareness and Diagnosis

    Growing awareness regarding GERD and NERD symptoms among the general population and healthcare providers is a crucial driver for the Global Americas GERD and NERD Treatment Market Industry. Enhanced educational initiatives and campaigns have led to improved diagnosis rates, allowing for timely intervention. As more individuals seek medical advice for reflux-related symptoms, the demand for diagnostic tools and treatment options is likely to rise. This trend is reflected in the projected compound annual growth rate (CAGR) of 8.36 percent from 2025 to 2035, indicating a robust market response to increased awareness and proactive healthcare measures.

    Rising Prevalence of GERD and NERD

    The increasing prevalence of gastroesophageal reflux disease (GERD) and non-erosive reflux disease (NERD) is a primary driver for the Global Americas GERD and NERD Treatment Market Industry. Recent estimates indicate that approximately 20 percent of the American population experiences GERD symptoms, contributing to a growing demand for effective treatment options. This trend is expected to continue, with the market projected to reach 2.16 USD Billion in 2024. The rising incidence of obesity and lifestyle factors, such as diet and stress, further exacerbate the condition, leading to a heightened focus on therapeutic interventions.

    Advancements in Treatment Modalities

    Innovations in treatment modalities significantly influence the Global Americas GERD and NERD Treatment Market Industry. The introduction of novel pharmacological agents, including proton pump inhibitors and H2 receptor antagonists, has transformed the management of GERD and NERD. Additionally, minimally invasive surgical techniques, such as fundoplication, have gained traction, offering patients effective alternatives to traditional surgery. As these advancements continue to evolve, they are likely to enhance patient outcomes and satisfaction, driving market growth. The anticipated expansion of the market to 5.22 USD Billion by 2035 underscores the importance of ongoing research and development in this field.

    Lifestyle Changes and Dietary Habits

    Shifts in lifestyle and dietary habits contribute to the rising incidence of GERD and NERD, thus impacting the Global Americas GERD and NERD Treatment Market Industry. The consumption of high-fat, spicy foods, and the prevalence of sedentary lifestyles have been linked to increased reflux symptoms. As awareness of these correlations grows, there is a potential for increased demand for therapeutic interventions. This trend may be further amplified by public health initiatives aimed at promoting healthier lifestyles, which could lead to a more proactive approach to managing GERD and NERD.

    Market Segment Insights

    Regional Insights

    Key Companies in the GERD and NERD Treatment Market market include

    Industry Developments

    Future Outlook

    GERD and NERD Treatment Market Future Outlook

    The Americas GERD & NERD Treatment Market is projected to grow at an 8.36% CAGR from 2024 to 2035, driven by increasing prevalence and advancements in treatment options.

    New opportunities lie in:

    • Develop innovative drug delivery systems to enhance patient compliance and treatment efficacy.
    • Invest in telehealth solutions for remote monitoring and management of GERD & NERD patients.
    • Explore partnerships with technology firms to integrate AI in diagnostic processes.

    By 2035, the market is expected to demonstrate robust growth, reflecting evolving treatment paradigms and patient needs.

    Market Segmentation

    Report Scope

    FAQs

    At what CAGR is the Americas GERD & NERD treatment market projected to grow during the forecast period?

    Americas GERD & NERD treatment market is projected to grow at a 7.63% CAGR By 2032

    Which region is expected to dominate the GERD & NERD treatment market?

    The Americas is expected to dominate the GERD & NERD treatment market.

    What are the key factors driving the Americas GERD & NERD treatment market?

    Rising incidence of reflux disorder and increasing cases of smoking are key factors driving the GERD & NERD treatment market.

    Which drug class segment will dominate the Americas GERD & NERD treatment market?

    Proton pump inhibitors will dominate the GERD & NERD treatment market.

    What are the end users of the Americas GERD & NERD treatment market?

    End users of the GERD & NERD treatment market include research centers, hospitals and clinics, and others.

    1. Report Prologue
    2. Market Introduction
      1. Definition 14
      2. Scope of the Study 14
        1. Research Objective 14
        2. Assumptions
        3. Limitations 14
      3. 14
    3. Research Methodology
      1. Research Methodology 17
      2. 17
      3. 18
      4. Research Methodology 20
      5. 22
    4. Primary
    5. Data Points Received from the Doctors/ Gastrologist:
    6. Data points received from the Manufacturer/ Pharmaceutical Companies:
    7. Data points received from Hospitals, Clinics: 18
    8. Secondary
    9. Market Share Analysis 22
    10. Trade Analysis
    11. Market Pricing Approach 22
    12. Market Dynamics
      1. Introduction
      2. 23
      3. Drivers 24
        1. Increasing cases of smoking to boost the market
        2. Rising cases of reflux disorder during
        3. Changing lifestyle and irregular
        4. Increasing incidence of acid
        5. Growing geriatric population (impact weightage-
        6. Increasing demands for endoscopy biopsy procedures for early
      4. growth (Impact weightage- 20%) 24
      5. pregnancy (impact weightage- 15%) 25
      6. dietary habits (Impact weightage- 15%) 26
      7. reflux disorder (heartburn) will boost the American GERD& NERD treatment market
      8. (Impact weightage- 25%) 27
      9. 15%) 28
      10. diagnosis (Impact weightage- 10%) 29
      11. Restraints 30
        1. Loss of patent
        2. High
      12. exclusivity and lack of pipeline drugs (impact weightage- 55%) 30
      13. cost of the gastroscopes (weightage impact- 45%) 31
      14. Opportunity 32
      15. 4.4.1
      16. Development of new drugs 32
      17. Mega Trends 32
      18. Macroeconomic Indicators
      19. 32
      20. Technology Trends & Assessment 33
    13. Market Factor
      1. Analysis
      2. Porters Five forces Model 34
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers 35
        3. Threat of New Entrants 35
        4. Threat of Substitutes 35
        5. Intensity of Rivalry 36
      3. 35
      4. Value
        1. R&D 37
        2. Manufacturing 37
        3. Distribution
        4. Post-Sales Monitoring 37
      5. Chain Analysis 36
      6. & Sales 37
      7. Demand & Supply:
      8. Gap Analysis 38
      9. Pricing Analysis 38
      10. Investment Opportunity Analysis
      11. 38
    14. Americas GERD & NERD Treatment Market, by Drug class
      1. 6.1
      2. Introduction 39
      3. Antacids (Acid Neutralizers) 40
      4. Proton Pump Inhibitors
        1. Esomeprazole 41
        2. Omeprazole 42
        3. Pantoprazole 42
        4. Lansoprazole 43
        5. Dexlansoprazole 43
        6. Rabeprazole 43
      5. 41
      6. H2 receptor blocker 44
        1. Ranitidine 44
        2. Famotidine 45
        3. Cimetidine 45
        4. Nizatidine 46
      7. Pro kinetic agents 46
        1. Domperidone 46
        2. Metoclopramide 47
        3. Itopride 47
        4. Cisapride 48
        5. Benzamide 48
        6. Mosapride
        7. Erythromycin 49
      8. 6.5.4
      9. Prucalopride 47
      10. 48
      11. Antidepressants 49
      12. Calcium Channel
      13. Blockers 50
    15. Americas GERD & NERD Treatment Market, by Dosage Form
      1. Introduction 51
      2. Solid 52
      3. Liquid 52
    16. Americas
    17. GERD & NERD Treatment Market, by End User
      1. Introduction 53
      2. 8.2
      3. Hospitals & Clinics 54
      4. Research Centers 54
    18. Americas GERD
    19. & NERD Treatment Market, by Region
      1. Introduction 55
      2. North America
        1. U.S. 60
        2. Canada 63
      3. 57
      4. South America 66
      5. 10
      6. Competitive Landscape
      7. Introduction 69
      8. Company Share Analysis
      9. 69
    20. Company Profiles
      1. AstraZeneca 70
        1. Company Overview
        2. Financials 70
        3. Products 70
        4. Strategy 70
        5. Key Developments 70
      2. 70
      3. Addex Pharmaceuticals 71
        1. Company
        2. Financials 71
        3. Products 71
        4. Strategy
        5. Key Developments 71
      4. Overview 71
      5. 71
      6. Takeda Pharmaceutical 72
        1. Financials 72
        2. Products 72
        3. Key Developments 72
      7. 11.3.1
      8. Company Overview 72
      9. 11.3.4
      10. Strategy 72
      11. Eisai Co., Ltd 73
        1. Financials 73
        2. Products 73
        3. Key Developments 73
      12. 11.4.1
      13. Company Overview 73
      14. 11.4.4
      15. Strategy 73
      16. Medigus Ltd 74
        1. Financials 74
        2. Products 74
        3. Key Developments 74
      17. 11.5.1
      18. Company Overview 74
      19. 11.5.4
      20. Strategy 74
      21. RaQualia Pharma Inc 75
        1. Company Overview 75
        2. Financials 75
        3. Products 75
        4. Strategy 75
        5. Key Developments 75
      22. Torax Medical 76
        1. Company Overview 76
        2. Financials 76
        3. Products 76
        4. Strategy 76
        5. Key Developments 76
      23. Carbon Medical technologies
        1. Company Overview 77
        2. Financials 77
        3. Products
        4. Strategy 77
        5. Key Developments 77
      24. 77
      25. 77
      26. Endogastric
        1. Company Overview 78
        2. Financials 78
        3. Strategy 78
        4. Key Developments 78
      27. Solutions 78
      28. 11.9.3
      29. Products 78
      30. Medtronic
        1. Company Overview 79
        2. Financials 79
        3. Products
        4. Strategy 79
        5. Key Developments 79
      31. 79
      32. 79
      33. Pfizer 80
        1. Company Overview 80
        2. Financials 80
        3. Products 80
        4. Strategy 80
        5. Key Developments 80
      34. Novartis AG. 81
        1. Company Overview 81
        2. Financials 81
        3. Products 81
        4. Strategy 81
        5. Key Developments 81
      35. GlaxoSmithKline
        1. Company Overview 82
        2. Financials 82
        3. Strategy 82
        4. Key Developments 82
        5. Company Overview 83
        6. Financials
        7. Products 83
        8. Strategy 83
        9. Key Developments
      36. plc 82
      37. 11.13.3
      38. Products 82
      39. 11.14
      40. Valeant Pharmaceuticals 83
      41. 83
      42. 83
      43. Ironwood Pharmaceuticals, Inc. 84
        1. Company Overview 84
        2. Financials 84
        3. Products 84
        4. Strategy 84
      44. 11.15.5
      45. Key Developments 84
    21. Appendix
      1. Discussion Blue Print 85
    22. MRFR Conclusion
      1. Key Findings 87
        1. From CEO’s View
        2. Unmet Needs 87
      2. Point 87
      3. Key companies to watch 87
    23. List of Tables
    24. PRIMARY INTERVIEWS 19
    25. AMERICAS GERD
    26. & NERD TREATMENT MARKET, BY ANTACIDS (ACID NEUTRALIZERS), 2023 & 2030 (USD
      1. MILLION) 40
    27. AMERICAS GERD & NERD TREATMENT MARKET, BY PROTON PUMP
      1. INHIBITORS, 2023 TO 2030 (USD MILLION) 41
    28. AMERICAS GERD & NERD
    29. TREATMENT MARKET, BY ESOMEPRAZOLE, 2023 TO 2030 (USD MILLION) 41
    30. AMERICAS
    31. GERD & NERD TREATMENT MARKET, BY OMEPRAZOLE, 2023 TO 2030 (USD MILLION) 42
    32. AMERICAS GERD & NERD TREATMENT MARKET, BY PANTOPRAZOLE, 2023 TO 2030
      1. (USD MILLION) 42
    33. AMERICAS GERD & NERD TREATMENT MARKET, BY LANSOPRAZOLE,
    34. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY DEXLANSOPRAZOLE, 2023 TO 2030 (USD MILLION) 43
    35. AMERICAS GERD &
    36. NERD TREATMENT MARKET, BY RABEPRAZOLE, 2023 TO 2030 (USD MILLION) 43
      1. TABLE
    37. AMERICAS GERD & NERD TREATMENT MARKET, BY H2 RECEPTOR BLOCKER, 2023 TO 2030
      1. (USD MILLION) 44
    38. AMERICAS GERD & NERD TREATMENT MARKET, BY RANITIDINE,
    39. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY FAMOTIDINE, 2023 TO 2030 (USD MILLION) 45
    40. AMERICAS GERD& NERD
    41. TREATMENT MARKET, BY CIMETIDINE, 2023 TO 2030 (USD MILLION) 45
    42. AMERICAS
    43. GERD & NERD TREATMENT MARKET, BY NIZATIDINE, 2023 TO 2030 (USD MILLION) 46
    44. AMERICAS GERD & NERD TREATMENT MARKET, BY DOMPERIDONE, 2023 TO 2030
      1. (USD MILLION) 46
    45. AMERICAS GERD & NERD TREATMENT MARKET, BY METOCLOPRAMIDE,
    46. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY ITOPRIDE, 2023 TO 2030 (USD MILLION) 47
    47. AMERICAS GERD & NERD
    48. TREATMENT MARKET, BY PRUCALOPRIDE, 2023 TO 2030 (USD MILLION) 47
    49. AMERICAS
    50. GERD & NERD TREATMENT MARKET, BY CISAPRIDE, 2023 TO 2030 (USD MILLION) 48
    51. AMERICAS GERD & NERD TREATMENT MARKET, BY BENZAMIDE, 2023 TO 2030
      1. (USD MILLION) 48
    52. AMERICAS GERD & NERD TREATMENT MARKET, BY MOSAPRIDE,
    53. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY ERYTHROMYCIN, 2023 TO 2030 (USD MILLION) 49
    54. AMERICAS GERD &
    55. NERD TREATMENT MARKET, BY ANTIDEPRESSANTS, 2023 TO 2030 (USD MILLION) 49
      1. TABLE
    56. AMERICAS GERD & NERD TREATMENT MARKET, BY CALCIUM CHANNEL BLOCKERS, 2023
      1. TO 2030 (USD MILLION) 50
    57. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY SOLID, 2023 TO 2030 (USD MILLION) 52
    58. AMERICAS GERD & NERD TREATMENT
    59. MARKET, BY LIQUID, 2023 TO 2030 (USD MILLION) 52
    60. AMERICAS GERD &
    61. NERD TREATMENT MARKET, BY HOSPITALS & CLINICS, 2023 TO 2030 (USD MILLION) 54
    62. AMERICAS GERD & NERD TREATMENT MARKET, BY RESEARCH CENTERS, 2023
      1. TO 2030 (USD MILLION) 54
    63. AMERICAS GERD & NERD TREATMENT MARKET,
      1. BY REGION, 2023 TO 2030 (USD MILLION) 56
    64. NORTH AMERICA GERD &
    65. NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 57
    66. NORTH
    67. AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 57
    68. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
      1. MILLION) 58
    69. NORTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE,
    70. NORTH AMERICA GERD & NERD TREATMENT
    71. MARKET, BY DOSAGE FORM, 2023-2030 (USD MILLION) 59
    72. NORTH AMERICA GERD
    73. & NERD TREATMENT MARKET, BY END USER, 2023-2030 (USD MILLION) 59
      1. TABLE
    74. U.S. GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION)
      1. 60
    75. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
      1. MILLION) 60
    76. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030
      1. (USD MILLION) 61
    77. U.S. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030
      1. (USD MILLION) 61
    78. U.S. GERD & NERD TREATMENT MARKET, BY DOSAGE
      1. FORM, 2023-2030 (USD MILLION) 62
    79. U.S. GERD & NERD TREATMENT MARKET,
      1. BY END USER, 2023-2030 (USD MILLION) 62
    80. CANADA GERD & NERD TREATMENT
    81. MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 63
    82. CANADA GERD &
    83. NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 63
    84. CANADA
    85. GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
      1. TABLE
    86. CANADA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 64
    87. CANADA GERD & NERD TREATMENT MARKET, BY DOSAGE FORM, 2023-2030 (USD
      1. MILLION) 65
    88. CANADA GERD & NERD TREATMENT MARKET, BY END USER,
    89. SOUTH AMERICA GERD & NERD TREATMENT
    90. MARKET, BY DRUG CLASS, 2023-2030 (USD MILLION) 66
    91. SOUTH AMERICA GERD
    92. & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 66
    93. SOUTH
    94. AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD MILLION) 67
    95. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY TYPE, 2023-2030 (USD
      1. MILLION) 67
    96. SOUTH AMERICA GERD & NERD TREATMENT MARKET, BY DOSAGE
      1. FORM, 2023-2030 (USD MILLION) 68
    97. SOUTH AMERICA GERD & NERD TREATMENT
    98. MARKET, BY END USER, 2023-2030 (USD MILLION) 68
    99. List of Figures
    100. AMERICAS GERD & NERD TREATMENT MARKET, BY DRUG CLASS, 2023 &
    101. AMERICAS GERD & NERD TREATMENT MARKET, BY
      1. DOSAGE FORM, 2023 & 2030 (USD MILLION) 12
    102. AMERICAS GERD &
    103. NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD MILLION) 13
      1. FIGURE
    104. MARKET STRUCTURE 15
    105. RESEARCH METHODOLOGY 16
    106. DATA TRIANGULATION
      1. PRIMARY 19
    107. DATA TRIANGULATION METHOD 21
    108. PORTER’S
      1. FIVE FORCES MODEL 34
    109. AMERICAS GERD & NERD TREATMENT MARKET, BY
      1. DRUG CLASS, 2023 & 2030 (USD MILLION) 39
    110. AMERICAS GERD &
    111. NERD TREATMENT MARKET, BY DOSAGE FORM, 2023 & 2030 (USD MILLION) 51
      1. FIGURE
    112. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER, 2023 & 2030 (USD
      1. MILLION) 53
    113. AMERICAS GERD & NERD TREATMENT MARKET, BY END USER,

    Americas GERD & NERD Treatment Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions